Drugs / 62Cu-ethylglyoxal bis(thiosemicarbazone)
62Cu-ethylglyoxal bis(thiosemicarbazone)
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00714142 Comparator | Aug 2008 → Apr 2009 | kidney failure, renal artery obstruction | Jeffrey L. Lacy | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 62Cu-ethylglyoxal bis(thiosemicarbazone) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00714142 ↗ |
| Modality | Diagnostic / imaging agent | “Using positron emission tomography (PET scan) the researchers can see the tracer and can learn more about how the blood moves through the kidneys.” NCT00714142 ↗ |
| Route | Intravenous | “15-25 mCi, IV” NCT00714142 ↗ |